Wealth Enhancement Advisory Services’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.4K Buy
+11,073
New +$16K ﹤0.01% 4008
2026
Q1
Sell
-136,587
Closed -$325K 3720
2025
Q4
$325K Sell
136,587
-883
-0.6% -$2.42K ﹤0.01% 2854
2025
Q3
$392K Buy
+137,470
New +$471K ﹤0.01% 2562

Other funds holding HCAT

Wealth Enhancement Advisory Services's HCAT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Health Catalyst (HCAT) in Q2 2026: 11,073 shares worth $25.4K. The stake represents ﹤0.01% of the portfolio and ranks #4008 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in HCAT as recently as Q4 2025.

Wealth Enhancement Advisory Services first reported a position in HCAT in Q3 2025 and has held it in 3 quarters since. The position peaked at $392K in Q3 2025. 8 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 11,073 shares of Health Catalyst worth $25.4K as of Q2 2026.
  • Health Catalyst was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #4008 holding.
  • Wealth Enhancement Advisory Services first reported a position in Health Catalyst in Q3 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Advisory Services's Health Catalyst position peaked at $392K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.